Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-12-01T00:24:53.070Z Has data issue: false hasContentIssue false
  • English
  • Français

The American Red Cross Experience with HTLV-I

Published online by Cambridge University Press:  21 June 2016

Roger Y. Dodd ,
Chyang T. Fang  and
Alan E. Williams
Roger Y. Dodd
Affiliation:
American Red Cross, Jerome H. Holland Laboratories, 15601 Crabbs Branch Way, Rockville, Maryland
Chyang T. Fang
Affiliation:
American Red Cross, Jerome H. Holland Laboratories, 15601 Crabbs Branch Way, Rockville, Maryland
Alan E. Williams
Affiliation:
American Red Cross, Jerome H. Holland Laboratories, 15601 Crabbs Branch Way, Rockville, Maryland
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Extended Abstracts
Information
Infection Control & Hospital Epidemiology , Volume 9 , Issue 8 , August 1988 , pp. 357 - 358
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1988 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Poiesz, BJ, Ruscetti, FW, Gazdar, AF, et al: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980: 77:7415–7419.10.1073/pnas.77.12.7415Google Scholar
2. Robert-Guroff, M, Weiss, SH, Giron, JA, et al: Prevalence of antibodies to HTLV I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA 1986; 255:3133–3137.10.1001/jama.1986.03370220095034Google Scholar
3. Okochi, K, Sato, H, Hinuma, Y: A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: Sero-conversion in recipients. Vox Sang 1984; 46:245–253.10.1111/j.1423-0410.1984.tb00083.xGoogle Scholar
4. Osame, M, Izumo, S, Igata, A, et al: Blood transf usion and HTLV-I associated myelopathy. Lancet 1986: 2:104–105.10.1016/S0140-6736(86)91636-3Google Scholar
5. Minamoto, GY, Gold, JWM, Scheinberg, DA, et al: Infection with human T-cell leukemia virus type I in patients with leukemia. N Engl J Med 1988; 318:219–222.10.1056/NEJM198801283180405Google Scholar
6. Jason, JM, McDougal, JS, Cabradilla, C, et al: Human T-cell leukemia virus (HTLV-I) p24 antibody in New York City blood product recipients. Am J Hematol 1984; 20:129–137.10.1002/ajh.2830200205Google Scholar
7. Fang, CT, Williams, AE, Sandler, SG. et al: Detection of antibodies to human T-lymphotropic virus type 1 (HTLV-I). Transfusion 1988; 28:179–183.10.1046/j.1537-2995.1988.28288179027.xGoogle Scholar
8. Williams, AE, Fang, CT, Slamon, DJ. et al: Seroprevalence and epidemiologic correlates of HTLV-I infection in blood donors from the United States. Science 1988: 240:000–000.10.1126/science.2896386Google Scholar